Trials / Completed
CompletedNCT01078285
Effectiveness Of A Program That Includes Counseling And Patient Support On Adherence To Treatment With Lipitor
Impact Of An Integrated Intervention Program On Adherence To Atorvastatin
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (actual)
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
Despite extensive reports of the benefits of statins in reducing serious cardiovascular events such as stroke and heart disease in patients with elevated LDL-cholesterol, patients do not take their medicines regularly as prescribed. Reasons include forgetfulness, lack of understanding of the seriousness of the disease, and fear of side effects. An intervention strategy comprising 3-5 minutes of counseling, emotional support and cost-sharing may be motivational and improve adherence to treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | No Patient Counseling | Patients do not receive any adherence counseling, or other patient support services |
| BEHAVIORAL | Adherence Counseling | Patients receive 3-5 minutes of adherence counseling, and other patient support services |
Timeline
- Start date
- 2010-03-01
- Primary completion
- 2011-11-01
- Completion
- 2011-11-01
- First posted
- 2010-03-02
- Last updated
- 2021-02-18
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01078285. Inclusion in this directory is not an endorsement.